ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,442.00
      2.14%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      62,887.17
      0.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PhenomeX Inc (CELL)

      7. PhenomeX Inc (CELL) News

      CELL

      PhenomeX (CELL)

      PhenomeX Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CELL
      DateTimeSourceHeadlineSymbolCompany
      02/08/20245:58PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELLPhenomeX Inc
      10/12/20239:00AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CELLPhenomeX Inc
      10/03/20233:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
      10/03/20233:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
      10/03/20232:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
      10/02/20235:16PMEdgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:CELLPhenomeX Inc
      10/02/20235:06PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
      10/02/20235:05PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
      10/02/20235:04PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
      10/02/20235:03PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
      10/02/20235:02PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
      10/02/20238:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
      09/29/20238:30AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CELLPhenomeX Inc
      09/27/20238:51AMPR Newswire (US)PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic PlatformNASDAQ:CELLPhenomeX Inc
      09/21/20238:35AMPR Newswire (US)PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development WorkflowsNASDAQ:CELLPhenomeX Inc
      09/20/20238:48AMPR Newswire (US)PhenomeX to Participate in Upcoming Cell Biology ConferencesNASDAQ:CELLPhenomeX Inc
      09/20/20236:05AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CELLPhenomeX Inc
      09/15/20239:08AMPR Newswire (US)PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free ProteomicsNASDAQ:CELLPhenomeX Inc
      09/05/20234:02PMPR Newswire (US)PhenomeX Inc. Announces Commencement of Cash Tender Offer by BrukerNASDAQ:CELLPhenomeX Inc
      08/31/20234:47PMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CELLPhenomeX Inc
      08/28/20235:04PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CELLPhenomeX Inc
      08/18/20235:21PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
      08/17/20235:28PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
      08/17/20235:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
      08/17/20239:10AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
      08/17/20239:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
      08/17/20239:00AMBusiness WireBruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash TransactionNASDAQ:CELLPhenomeX Inc
      08/14/20234:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELLPhenomeX Inc
      08/14/20234:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
      08/14/20234:05PMPR Newswire (US)PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CELLPhenomeX Inc
       Showing the most relevant articles for your search:NASDAQ:CELL